Skip to main content
. 2017 May 26;8(43):74139–74158. doi: 10.18632/oncotarget.18274

Table 4. The correlation of three lncRNAs and risk score with clinicopathological parameters (TCGA dataset, N = 449).

Clinicopathological parameters AC079630.2 (P) CRNDE (P) CTD-2171N6.1 (P) Risk score (P)
Age 0.122 0.115 0.092 0.004
Gender 0.602 0.016 0.077 0.963
Tumor subtypes 0.508 0.226 0.001 0.013
History of other tumor 0.71 0.265 0.237 0.226
Pathological stage 0.598 0.074 0.523 0.319
T stage 0.612 0.346 0.342 0.303
N stage 0.057 0.698 0.062 0.308
M stage 0.805 0.209 0.137 0.173
Focus types 0.261 0.922 0.393 0.971
Extrathyroidal extension 0.666 0.251 0.264 0.872
BRAFV600E 0.982 0.105 0.045 0.006

P: P- values of Spearman rank correlation.